Microbead-Free Waters Act of 2015

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; H.R. 4923, American Manufacturing Competitiveness Act of 2016; H.R. 5538, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; S. 2794, American Manufacturing Competitiveness Act of 2016; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Building and Construction water infrastructure; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Labeling, including GMOs; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Titanium Dioxide; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Client expense: $2,190,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of

FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Clean Air Act regulations, climate change, ozone protection, greenhouse gas reporting, fluorochemicals, hyrdofluorocarbons and/or refrigerants and/or the Montreal Protocol and United Nations supporting language. Issues related to natural gas. Issues related to ground-level ozone EPA regulations. EPA chemical regulations, including Significant New Alternatives Policy program regulations and EPA risk management program regulations and EPA corrosivity regulations. H.R. 1321 - Microbeads-Free Waters Act of 2015 and S. 1424 Microbeads-Free Waters Act of 2015 monitor implementation and related issues. S. 2076 - Super Pollutants Act of 2015 and H.R. 508, SUPER Act of 2015; S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments.

Client expense: $140,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)

H.R.1321 - Microbead-Free Waters Act of 2015

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 185, Regulatory Accountability Act of 2015; H.R. 212, To amend the Safe Drinking Water Act to provide for the assessment and management of the risk of algal toxins in drinking water, and for other purposes; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 1327, ORDEAL Act of 2015; H.R. 1388, Clean Air, Strong Economies Act; H.R. 1960, Land-Based Marine Debris Reduction Act; H.R. 2557, Promoting New Manufacturing Act; H.R. 4265, Clean Air Implementation Act of 2015; H.R. 4775, Ozone Standards Implementation Act of 2016; H.R. 5538, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S. 460, Drinking Water Protection Act; S. 638, Commonsense Legislative Exceptional Events Reforms Act of 2015; S. 640, ORDEAL Act of 2015; S. 751, CASE Act; S. 1140, Federal Water Quality Protection Act; S. 1424, Microbead-Free Waters Act of 2015; S. 1425, Promoting New Manufacturing Act; S. 2882, The Ozone Standards Implementation Act; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S.J.Res.24, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of a rule submitted by the Environmental Protection Agency relating to "Carbon Pollution Emission Guidelines for Existing Stationary Sources: Electric Utility Generating Units"; FY 2016 Appropriations for Environmental Protection Agency; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; Clean Air Act Legislation and Regulations (Including Ozone); Clean Power Plan Legislation Review; EPA General Duty Clause Legislation; Marine Debris; Microbeads and Microplastics; NAAQS; Ozone Legislation; Plastic Piping; Risk Management Program; SNAP; Sustainability; Water Infrastructure; Water Resource Development Act Draft Legislation;

Client expense: $2,750,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; H.R. 4923, American Manufacturing Competitiveness Act of 2016; H.R. 5538, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; S. 2794, American Manufacturing Competitiveness Act of 2016; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Building and Construction water infrastructure; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Client expense: $2,750,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of

- Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 1321 / S.1424, Microbead Free Waters Act of 2015 - HR 4075, Cosmetic Modernization Amendments of 2015 - S.1014, The Personal Care Products Safety Act

Client expense: $783,084 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

Support for The Frank R. Lautenberg Chemical Safety for the 21st Century Act (S. 697), and TSCA Modernization Act of 2015 (H.R. 2576); Support for Superfund and sediment remediation policy. Support for Ozone Standard legislation (S. 751, S. 1425, S. 640, H.R. 1388, H.R. 1044, H.R. 1327), Waters of the U.S. legislation (S. 1140/H.R. 1732), Clean Power Plan legislation (H.R. 2042/S. 1324). Support for H.R. 1321, the Microbead-Free Waters Act of 2015. Support for certain provisions of WRDA, S. 2848.

Client expense: $2,870,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Railroad Administration, Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Issues related to Clean Air Act regulations, climate change, ozone protection, greenhouse gas reporting, fluorochemicals, hyrdofluorocarbons and/or refrigerants and/or the Montreal Protocol. Issues related to natural gas. Issues related to ground-level ozone EPA regulations. EPA chemical regulations, including Significant New Alternatives Policy program regulations and EPA risk management program regulations and EPA corrosivity regulations. H.R. 1321 - Microbeads-Free Waters Act of 2015 and S. 1424 Microbeads-Free Waters Act of 2015 monitor implementation and related issues. S. 2076 - Super Pollutants Act of 2015 and H.R. 508, SUPER Act of 2015; S. 1014, Personal Care Products Safety Act and H.R. 4075, Cosmetic Modernization Amendments.

Client expense: $100,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)

FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- HR 1321, "Microbead-Free Waters Act of 2015", regarding all provisions. - S 697, "Frank R. Lautenberg Chemical Safety for the 21st Century Act", regarding all provisions.

Client expense: $1,140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

- Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 1321 / S.1424, Microbead Free Waters Act of 2015 - HR 4075, Cosmetic Modernization Amendments of 2015 - S.1014, The Personal Care Products Safety Act

Client expense: $925,001 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Client expense: $1,220,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of

H.R. 185, Regulatory Accountability Act of 2015; H.R. 212, To amend the Safe Drinking Water Act to provide for the assessment and management of the risk of algal toxins in drinking water, and for other purposes; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 1327, ORDEAL Act of 2015; H.R. 1388, Clean Air, Strong Economies Act; H.R. 1960, Land-Based Marine Debris Reduction Act; H.R. 2557, Promoting New Manufacturing Act; H.R. 4265, Clean Air Implementation Act of 2015; H.R. 4775, Ozone Standards Implementation Act of 2016; S. 460, Drinking Water Protection Act; S. 638, Commonsense Legislative Exceptional Events Reforms Act of 2015; S. 640, ORDEAL Act of 2015; S. 751, CASE Act; S. 1140, Federal Water Quality Protection Act; S. 1424, Microbead-Free Waters Act of 2015; S. 1425, Promoting New Manufacturing Act; S.J.Res.24, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of a rule submitted by the Environmental Protection Agency relating to "Carbon Pollution Emission Guidelines for Existing Stationary Sources: Electric Utility Generating Units"; FY 2016 Appropriations for Environmental Protection Agency; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; Clean Air Act Legislation and Regulations (Including Ozone); Clean Power Plan Legislation Review; EPA General Duty Clause Legislation; Marine Debris; Microbeads and Microplastics; NAAQS; Ozone Legislation; Plastic Piping; SNAP; Sustainability; Water Infrastructure; Water Resource Development Act Draft Legislation;

Client expense: $1,220,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of

Microbeads - H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015. Would prohibit the distribution of cosmetic products containing synthetic plastic microbeads after July 1, 2017, and nonprescription drug products containing synthetic plastic microbeads after July 1, 2018; all sections. OTC Drug Review Monograph - legislation to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.

Client expense: $230,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

S. 1424, H.R. 1321, Microbead-free Waters Act of 2015

Client expense: $240,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. Issues related to H.R. 6, "21st Century Cures" and the Senate Medical Innovations package. Implementation of H.R.1321 - Microbead-Free Waters Act of 2015; Issues related to the over the counter drug monograph process. Issues related to the disposal of unused over the counter drugs.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for The Frank R. Lautenberg Chemical Safety for the 21st Century Act (S. 697), and TSCA Modernization Act of 2015 (H.R. 2576); Support for Superfund and sediment remediation policy. Support for Ozone Standard legislation (S. 751, S. 1425, S. 640, H.R. 1388, H.R. 1044, H.R. 1327), Waters of the U.S. legislation (S. 1140/H.R. 1732), Clean Power Plan legislation (H.R. 2042/S. 1324). Support for H.R. 1321, the Microbead-Free Waters Act of 2015.

Client expense: $4,790,982 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Railroad Administration, Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Issues related to Clean Air Act regulations, climate change, ozone protection, greenhouse gas reporting, fluorochemicals, hyrdofluorocarbons and/or refrigerants and/or the Montreal Protocol. Issues related to natural gas. Issues related to ground-level ozone EPA regulations. EPA chemical regulations, including Significant New Alternatives Policy program regulations and EPA risk management program regulations. H.R. 1321 - Microbeads-Free Waters Act of 2015 and S. 1424 Microbeads-Free Waters Act of 2015 monitor implementation and related issues. S. 2076 - Super Pollutants Act of 2015 and H.R. 508, SUPER Act of 2015.

Client expense: $180,000 · Firm income: Not reported

Government targets: Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Surface Transportation Board (STB), U.S. Trade Representative (USTR)

FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1321 - Microbead-Free Waters Act of 2015

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Sustainability issues; H.R. 8 - energy; H.R. 1321 - Microbead-Free Waters Act of 2015 (P.L. 114-114); EPA reverse logistics of consumer products/goods.

Client expense: $660,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Maritime Commission, Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. Issues related to H.R. 6, "21st Century Cures" and the Senate FDA and NIH modernization efforts. H.R.1321 - Microbead-Free Waters Act of 2015; Issues related to the over the counter drug monograph process.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Microbead-Free Waters Act of 2015 (HR 1321), EPA proposed new ozone standard, Clean Power Plan

Client expense: $410,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to NIH funding S. 320: Medical Innovation Act of 2015 - Provisions related to National Institutes of Health (NIH) funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the Controlled Substances Act (CSA) S. 683: Compassionate Access, Research Expansion, and Respect States Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 1128: Preserving Access to Orphan Drugs Act - Provisions related to orphan drug tax (113th Congress) S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: The Combination Product Regulatory Fairness Act of 2015 - Provisions related to improvements in the regulation of combination drug-device products S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation S. 2055 - the Medical Countermeasure Innovation Act of 2015 H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 471: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the CSA H.R. 639: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to DEA scheduling H.R. 880: American Research and Competitiveness Act of 2015 - Provisions related to the research and development (R&D) tax credit H.R. 909: Andrea Sloan Compassionate Use Reform and Enhancement Act - Provisions related to expanded access H.R. 1321: Microbead-Free Waters Act of 2015 - Provisions related to bills applicability to prescription drugs H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 1635: Charlottes Web Medical Access Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 2433: To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review - Provisions regarding the enhancement of combination products review H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2536: Recovery Enhancement for Addiction Treatment Act - Provisions related to the treatment of drug addiction H.R. 2629: Antibiotic Development to Advance Patient Treatment Act - Provisions related to the approval of certain drugs for use in a limited population of patients H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015 - Provisions related to the reauthorization of the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 2872: Opioid Addiction Treatment Modernization Act - Provisions related to the treatment of opioid addiction H.R. 3014: Medical Controlled Substances Transportation Act of 2015 - Provisions related to the transport of controlled substances by physicians in certain situations HR. 3299 - the Strengthening Public Health Emergency Response Act of 2015 H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3680: Co-Prescribing to Reduce Overdoses Act of 2015 - Provisions related to the prescribing of opioid overdose reversal drug to at-risk patients H.R. 3762, Restoring Americans Healthcare Freedom Reconciliation Act - Provisions related to amending and withdrawing funding from the Affordable Care Act The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act issues including the Charitable Donation Exemption Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed Rules [CMS-2390-P] Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker proposed legislation - Draft legislation related to developing a new approval pathway for biomarkers Rogue Internet Pharmacy policy issues Prescription drug abuse policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner

Client expense: $380,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Microbeads(HR 1321) support

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 471/S. 483, Ensuring Patient Access and Effective Drug Enforcement Act of 2015. H.R. 1735/S. 1356, Department of Defense Appropriations Act, FY 2016, health care provisions. Implementation issues related to the Patient Protection and Affordable Care Act (P.L. 111-148). H.R. 6, 21st Century Cures Act. H.R. 639, Improving Regulatory Transparency for New Medical Therapies Act. H.R. 1321, Microbead-Free Waters Act of 2015. H.R. 2029, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, FY 2016, health care provisions.

Client expense: $580,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.1321/S.1424, "Microbead-Free Waters Act of 2015", provisions related to the regulation of cosmetics.

Client expense: $360,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, U.S. Postal Service (USPS)

- Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 1321 / S.1424, Microbead Free Waters Act of 2015 - S.1014, The Personal Care Products Safety Act

Client expense: $1,190,507 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

- HR 1321, "Microbead-Free Waters Act of 2015", regarding all provisions. - S 697, "Frank R. Lautenberg Chemical Safety for the 21st Century Act", regarding all provisions.

Client expense: $1,210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Microbeads - H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015. Would prohibit the distribution of cosmetic products containing synthetic plastic microbeads after July 1, 2017, and nonprescription drug products containing synthetic plastic microbeads after July 1, 2018; all sections. OTC Drug Review Monograph - legislation to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.

Client expense: $315,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

S. 1424, H.R. 1321, Microbead-free Waters Act of 2015

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1321 - Microbead-Free Waters Act of 2015

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 185, Regulatory Accountability Act of 2015; H.R. 212, To amend the Safe Drinking Water Act to provide for the assessment and management of the risk of algal toxins in drinking water, and for other purposes; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 1327, ORDEAL Act of 2015; H.R. 1388, Clean Air, Strong Economies Act; H.R. 1960, Land-Based Marine Debris Reduction Act; H.R. 2557, Promoting New Manufacturing Act; H.R. 4265, Clean Air Implementation Act of 2015; S. 460, Drinking Water Protection Act; S. 638, Commonsense Legislative Exceptional Events Reforms Act of 2015; S. 640, ORDEAL Act of 2015; S. 751, CASE Act; S. 1140, Federal Water Quality Protection Act; S. 1424, Microbead-Free Waters Act of 2015; S. 1425, Promoting New Manufacturing Act; S.J.Res.24, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of a rule submitted by the Environmental Protection Agency relating to "Carbon Pollution Emission Guidelines for Existing Stationary Sources: Electric Utility Generating Units"; FY 2016 Appropriations for Environmental Protection Agency; Clean Air Act Legislation and Regulations (Including Ozone); Clean Power Plan Legislation Review; EPA General Duty Clause Legislation; Marine Debris; Microbeads and Microplastics; NAAQS; Ozone Legislation; SNAP; Sustainability; Water Infrastructure

Client expense: $3,320,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Client expense: $3,320,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of

FDA regulation of cosmetics. Consumer product safety issues. H.R. 1139 and S. 588, Detergent PACS Act of 2015. H.R. 1321 and S. 1424, Microbead-Free Waters Act of 2015. H.R. 3250, DXM Abuse Prevention Act of 2015. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to National Institutes of Health (NIH) funding S. 320: Medical Innovation Act of 2015 - Provisions related to NIH funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the Controlled Substances Act (CSA) S. 683: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 1128: Preserving Access to Orphan Drugs Act - Provisions related to orphan drug tax (113th Congress) S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2015 - Provisions related to improvements in the regulation of combination drug-device products S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 471: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the CSA H.R. 639: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to DEA scheduling H.R. 880: American Research and Competitiveness Act of 2015 - Provisions related to the research and development (R&D) tax credit H.R. 909: Andrea Sloan Compassionate Use Reform and Enhancement Act - Provisions related to expanded access H.R. 1321: Microbead-Free Waters Act of 2015 - Provisions related to bills applicability to prescription drugs H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 1635: Charlottes Web Medical Access Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 2433: To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review - Provisions regarding the enhancement of combination products review H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2536: Recovery Enhancement for Addiction Treatment Act - Provisions related to the treatment of drug addiction H.R. 2629: Antibiotic Development to Advance Patient Treatment Act - Provisions related to the approval of certain drugs for use in a limited population of patients H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015 - Provisions related to the reauthorization of the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 2872: Opioid Addiction Treatment Modernization Act - Provisions related to the treatment of opioid addiction H.R. 3014: Medical Controlled Substances Transportation Act of 2015 - Provisions related to the transport of controlled substances by physicians in certain situations H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3680: Co-Prescribing to Reduce Overdoses Act of 2015 - Provisions related to the prescribing of opioid overdose reversal drug to at-risk patients H.R. 3762, Restoring Americans Healthcare Freedom Reconciliation Act of 2015 - Provisions related to amending and withdrawing funding from the Affordable Care Act The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act issues including the Charitable Donation Exemption Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed rules [CMS-2390-P] - Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker proposed legislation - Draft legislation related to developing a new approval pathway for biomarkers Rogue Internet Pharmacy policy issues Prescription drug abuse policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner

Client expense: $3,820,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

H.R. 1321, Microbead-Free Waters Act of 2015; S. 1014, Personal Care Products Safety Act.

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1321, Microbead-Free Waters Act of 2015; S. 1014, Personal Care Products Safety Act.

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Microbead-Free Waters Act of 2015 (HR 1321), EPA proposed new ozone standard, Clean Power Plan

Client expense: $480,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- HR 1321, "Microbead-Free Waters Act of 2015", regarding all provisions. - S 697, "Frank R. Lautenberg Chemical Safety for the 21st Century Act", regarding all provisions.

Client expense: $1,260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

S.1014; Personal Care Products Safety Act; entire bill. H.R. 1321; Microbead-Free Waters Act of 2015; entire bill. S.1424; Microbead-Free Waters Act of 2015; entire bill. H.R. 2293; Preventing Animal Cruelty & Torture Act; entire bill.

Client expense: $80,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Congressional oversight of EPA (e.g. Clean Water Rule, Clean Power Plan, Clean Air Act) EPA - Marine Debris - Trash Free Waters Microbead-Free Waters Act of 2015 (H.R. 1321)

Client expense: $50,000 · Firm income: Not reported

Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE, U.S. Trade Representative (USTR)

Sustainability issues; H.R. 8 - energy; H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015.

Client expense: $710,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Maritime Commission, Federal Reserve System, Federal Trade Commission (FTC), Financial Crimes Enforcement Network (FinCEN), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office